SYMPLICITY HTN-3 study

被引：0
|
作者：
Radziemski, Artur [1 ]
Kostka-Jeziorny, Katarzyna [1 ]
机构：
[1] Uniwersytetu Med Karola Marcinkowskiego Poznaniu, Katedra & Klin Hipertensjol Angiol & Chorob Wewne, Ul Dluga 1-2, PL-61848 Poznan, Poland
来源：
ARTERIAL HYPERTENSION | 2014年 / 18卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：51 / 55
页数：5
相关论文
共 50 条
  • [31] High screen failure rate in patients with resistant hypertension: Findings from SYMPLICITY HTN-3
    Waksman, Ron
    Bakris, George L.
    Steinvil, Arie
    Garcia-Garcia, Hector
    Brown, Angela L.
    DiFilippo, William
    Scott, Thomas
    Singh, Jasvindar
    DeBruin, Vanessa
    Jones, Denise
    Jolivette, Dan
    Bhatt, Deepak L.
    [J]. AMERICAN HEART JOURNAL, 2017, 192 : 76 - 84
  • [32] Assessment of hypertension control and clinical course of patients excluded from the SYMPLICITY HTN-3 trial
    Yerasi, Charan
    Baker, Nevin C.
    Jonnalagadda, Anil K.
    Torguson, Rebecca
    Singh, Suman
    Vies, Judith
    Waksman, Ron
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2015, 9 (12) : 959 - 965
  • [33] BEFORE SYMPLICITY HTN-3: SURVEY OF USER EXPERIENCE OF DHL HYPERTENSION SPECIALISTS WITH RENAL DENERVATION
    Kamalanabhaiah, S.
    Kolloch, R.
    Hoyer, J. D.
    [J]. JOURNAL OF HYPERTENSION, 2015, 33 : E493 - E493
  • [34] SYMPLICITY HTN-3: Outcomes in the African-American and non-African American Populations
    Flack, John
    Bakris, George L.
    Kandzari, David
    Katzen, Barry T.
    Leon, Martin
    Mauri, Laura
    O'Neill, William W.
    Oparil, Suzanne
    Rocha-Singh, Krishna
    Townsend, Raymond R.
    Bhatt, Deepak L.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B119 - B120
  • [35] Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension
    Elmula, Fadl Elmula M. Fadl
    Larstorp, Anne C.
    Kjeldsen, Sverre E.
    Persu, Alexandre
    Jin, Yu
    Staessen, Jan A.
    [J]. FRONTIERS IN PHYSIOLOGY, 2015, 6
  • [36] SYMPLICITY HTN-3 trial shows no significant effect of renal denervation on systolic blood pressure
    [J]. Nature Reviews Nephrology, 2014, 10 (6) : 299 - 299
  • [37] Catheter-Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN-3 Trial
    Kandzari, David E.
    Bhatt, Deepak L.
    Sobotka, Paul A.
    O'Neill, William W.
    Esler, Murray
    Flack, John M.
    Katzen, Barry T.
    Leon, Martin B.
    Massaro, Joseph M.
    Negoita, Manuela
    Oparil, Suzanne
    Rocha-Singh, Krishna
    Straley, Craig
    Townsend, Raymond R.
    Bakris, George
    [J]. CLINICAL CARDIOLOGY, 2012, 35 (09) : 528 - 535
  • [38] Opinion of the German Society of Cardiology on the Symplicity HTN-3 Study in Patients with resistant Arterial Hypertension after Renal Denervation
    Boehm, M.
    Hamm, C. W.
    Kuck, K. -H.
    Ertl, G.
    Mahfoud, F.
    Schunkert, H.
    [J]. KARDIOLOGE, 2014, 8 (03): : 244 - 245
  • [39] Renal denervation in treatment-resistant hypertension - Oslo RDN, Symplicity HTN-3 and INSPiRED randomized trials
    Kjeldsen, Sverre E.
    Narkiewicz, Krzysztof
    Oparil, Suzanne
    Hedner, Thomas
    [J]. BLOOD PRESSURE, 2014, 23 (03) : 135 - 137
  • [40] Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?
    Epstein, Murray
    de Marchena, Eduardo
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2015, 9 (02) : 140 - 149
12345